Terms ending in 2034
Every in-force patent on Sanofi's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,186,346 | Methods for Reducing the Risk of an Adverse Teriflunomide and Rosuvastatin Interaction in Multiple Sclerosis Patients In force · High confidence | Sanofi | In force | High confidence | |
| US 9,839,675 | Stabilized Pharmaceutical Formulations of Insulin Analogues And/Or Insulin Derivatives In force · High confidence | Sanofi | In force | High confidence | |
| US 9,937,252 | Induction of Cross-Reactive Cellular Response Against Rhinovirus Antigens In force · High confidence | Sanofi R&D Vaccins | In force | High confidence | |
| US 12,331,294 | MicroRNA Compounds and Methods for Modulating MIR-21 Activity In force · High confidence | Sanofi | In force | High confidence | |
| US 9,474,713 | Chewable Composition for Oral Administration and Process for Preparing Thereof In force · High confidence | Opella Healthcare Group SAS | In force | High confidence | |
| US 9,440,941 | Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals In force · High confidence | Sanofi | In force | High confidence | |
| US 9,718,825 | N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES and Their Use as Pharmaceuticals In force · High confidence | Sanofi | In force | High confidence | |
| US 9,663,524 | SUBSTITUTED PYRIDO[2,3-d]PYRIMIDINES AS PROTEIN KINASE INHIBITORS In force · High confidence | Bristol-Myers Squibb Company | In force | High confidence | |
| US 9,695,132 | Heteroaryl Compounds and Uses Thereof In force · High confidence | Bristol-Myers Squibb Company | In force | High confidence | |
| US 10,065,966 | SUBSTITUTED PYRIDO[2,3-d]PYRIMIDINES AS INHIBITORS OF PROTEIN KINASES In force · High confidence | Bristol-Myers Squibb Company | In force | High confidence | |
| 51 more term ends in 2034 · Pro | |||||
10 of 61 patents shown. Soonest term end first, then patent number.
Pro members see all 61.
45 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.